Abstract:Background Drug safety in children is a major concern; however, there is still a lack of methods for quantitatively measuring, let alone to improving, drug safety in children under different clinical conditions. To assess pediatric drug safety under different clinical conditions, a computational method based on Electronic Medical Record (EMR) datasets was proposed. Methods In this study, a computational method was designed to extract the significant drug-diagnosis associations (based on a Bonferroni-adjusted hypergeometric P-value < 0.05) among drug and diagnosis co-occurrence in EMR datasets. This allows for differences between pediatric and adult drug use to be compared based on different EMR datasets. The drug-diagnosis associations were further used to generate drug clusters under specific clinical conditions using unsupervised clustering. A 5-layer quantitative pediatric drug safety level was proposed based on the drug safety statement of the pediatric labeling of each drug. Therefore, the drug safety levels under different pediatric clinical conditions were calculated. Two EMR datasets from a 1900-bed children's hospital and a 2000-bed general hospital were used to test this method. Results The comparison between the children's hospital and the general hospital showed unique features of pediatric drug use and identified the drug treatment gap between children and adults. In total, 591 drugs were used in the children's hospital; 18 drug clusters that were associated with certain clinical conditions were generated based on our method; and the quantitative drug safety levels of each drug cluster (under different clinical conditions) were calculated, analyzed, and visualized. Conclusion With this method, quantitative drug safety levels under certain clinical conditions in pediatric patients can be evaluated and compared. If there are longitudinal data, improvements can also be measured. This method has the potential to be used in many population-level, health data-based drug safety studies.

Trends in Adverse Drug Reactions among Children: Evidence from Jiangsu Province of China, 2010–2019

Adverse drug reactions of spontaneous reports in Shanghai pediatric population.

Analysis of 145 ADR Reports of Children in Our Hospital in 2010

Reporting Patterns of Adverse Drug Reactions over Recent Years in China: Analysis from Publications

The Analysis of 358 Adverse Drug Reaction Reports in Children

A Computational Method to Quantitatively Measure Pediatric Drug Safety Using Electronic Medical Records

Adverse Drug Reaction Reporting in Institutions Across Six Chinese Provinces: A Cross-sectional Study.

Study on 990 Cases of Adverse Drug Reaction

Adverse Drug Reaction Reports in a 3A Hospital During 2005-2011:An Analysis of 10 097 Cases

Relative Risk Analysis of Liver-related Adverse Drug Reactions in Children Based on China's National Spontaneous Reporting System

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports

Analysis and Evaluation of the Adverse Drug Reaction Reports from the Drug Manufacturers in Shaanxi Province Between 2012 and 2014

Survey of Knowing and Reporting State about Children Adverse Drug Reactions

An Investigation of Pharmacovigilance and Reporting of Adverse Drug Reactions in Hospitals: a Cross-Sectional Study in China

Clinical analysis of severe adverse drug reactions in Peking Union Hospital from 2013 to 2015

Analysis of Top 5 Drugs in the Adverse Drug Reaction Report Database of Zhenjiang City in Recent 10 Years

Trends in Adverse Drug Reaction‐related Hospitalisations over 13 Years in New South Wales, Australia

2008-2011 Adverse Drug Reaction Analysis of 490 Cases in Huadong Hospital

Literature Analysis on Adverse Drug Reaction in China

Survey and analysis of correlation factors influencing medical staffs to report adverse drug reactions in children

Adverse drug reactions reported to liver injury in China: Database and reporting outlines